Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes …

IH de Boer, K Khunti, T Sadusky, KR Tuttle… - Diabetes …, 2022 - Am Diabetes Assoc
People with diabetes and chronic kidney disease (CKD) are at high risk for kidney failure,
atherosclerotic cardiovascular disease, heart failure, and premature mortality. Recent …

[HTML][HTML] A comprehensive review of cardiovascular disease management: cardiac biomarkers, imaging modalities, pharmacotherapy, surgical interventions, and …

VR Netala, SK Teertam, H Li, Z Zhang - Cells, 2024 - mdpi.com
Cardiovascular diseases (CVDs) continue to be a major global health concern, representing
a leading cause of morbidity and mortality. This review provides a comprehensive …

ACE-Inhibitors in Hypertension: A historical perspective and current insights

S Cutrell, IS Alhomoud, A Mehta, AH Talasaz… - Current hypertension …, 2023 - Springer
Abstract Purpose of Review This review describes the discovery and development of ACE
inhibitors as antihypertensive agents, compares their efficacy, tolerability, and safety to …

Angiotensin receptor blockers in the management of hypertension: a real-world perspective and current recommendations

G Gallo, M Volpe, S Rubattu - Vascular Health and Risk …, 2022 - Taylor & Francis
Hypertension represents a major common cardiovascular risk factor. Optimal control of high
blood pressure levels is recommended to reduce the global burden of hypertensive …

[HTML][HTML] The renin angiotensin system as a therapeutic target in traumatic brain injury

S Villapol, ZC Janatpour, KO Affram, AJ Symes - Neurotherapeutics, 2023 - Elsevier
Traumatic brain injury (TBI) is a major public health problem, with limited pharmacological
options available beyond symptomatic relief. The renin angiotensin system (RAS) is …

[HTML][HTML] Secondary ischemic stroke prevention

A Bangad, M Abbasi, A de Havenon - Neurotherapeutics, 2023 - Elsevier
The health burden of ischemic stroke is high and will continue to increase with an aging
population. Recurrent ischemic stroke is increasingly recognized as a major public health …

Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid …

DY Cao, Z Khan, X Li, S Saito… - Cardiovascular …, 2023 - academic.oup.com
Aims The metabolic failure of macrophages to adequately process lipid is central to the
aetiology of atherosclerosis. Here, we examine the role of macrophage angiotensin …

Angiotensin receptor blockers and cognition: a sco** review

Z Zhou, SG Orchard, MR Nelson, MA Fravel… - Current hypertension …, 2024 - Springer
Abstract Purpose of Review To provide an overview of the association between angiotensin
II receptor blocker (ARB) use and cognitive outcomes. Recent Findings ARBs have …

Valorization of chicken slaughterhouse byproducts to obtain antihypertensive peptides

FI Bravo, E Calvo, RA López-Villalba, C Torres-Fuentes… - Nutrients, 2023 - mdpi.com
Hypertension (HTN) is the leading cause of premature deaths worldwide and the main
preventable risk factor for cardiovascular diseases. Therefore, there is a current need for …

Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes

J Pawlonka, B Buchalska, K Buczma, H Borzuta… - … Treatment Options in …, 2024 - Springer
Opinion statement The renin–angiotensin–aldosterone system (RAAS) is a crucial regulator
of the cardiovascular system and a target for widely used therapeutic drugs. Dysregulation of …